AGIOS PHARMACEUTICALS INC Uncategorized Contracts & Agreements
14 Contracts & Agreements
- Letter Agreement, dated as of December 5, 2022, between the Registrant and Tsveta Milanova (Filed With SEC on February 23, 2023)
- Letter Agreement, dated September 16, 2022, by and between the Company and Cecilia Jones (Filed With SEC on November 3, 2022)
- Letter Agreement, dated as of July 8, 2022, between the Registrant and Brian Goff (Filed With SEC on August 4, 2022)
- Letter Agreement, dated as of July 27, 2021, between the Registrant and Chris Bowden, M.D (Filed With SEC on November 3, 2021)
- Letter Agreement, dated as of October 7, between the Registrant and Bruce Car (Filed With SEC on April 30, 2020)
- Letter Agreement, dated as of September 17, 2019, between the Registrant and Jonathan Biller (Filed With SEC on February 19, 2020)
- Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 19, 2020)
- Letter Agreement, dated as of August 30, 2018, between the Registrant and (Filed With SEC on November 1, 2018)
- Amended and Restated Letter Agreement, dated as of August 30, 2018, between the Registrant and David P. Schenkein, M.D (Filed With SEC on November 1, 2018)
- [Remainder of Page Intentionally Left Blank] (Filed With SEC on February 26, 2016)
- 38 Sidney Street, Suite 2 Cambridge, MA 02139 Main: 617 ###-###-#### Fax: 617 ###-###-#### www.agios.com (Filed With SEC on July 11, 2013)
- 38 Sidney Street, Suite2 Cambridge, MA 02139 Main: 617 ###-###-#### Fax: 617 ###-###-#### www.agios.com (Filed With SEC on July 11, 2013)
- 38 Sidney Street, Suite 2 Cambridge, MA 02139 Main: 617 ###-###-#### Fax: 617 ###-###-#### www.agios.com (Filed With SEC on July 11, 2013)
- 38 Sidney Street, Suite 2 Cambridge, MA 02139 Main: 617 ###-###-#### Fax: 617 ###-###-#### www.agios.com (Filed With SEC on June 10, 2013)
